Inflammation plays a role across many disease areas, but most significantly in immunological and auto-immune diseases, genetic disorders, chronic respiratory ailments and other conditions unified by the body’s innate immune response. Because the impact is so far reaching, we are committed to the prevention and treatment of these disorders through biopharmaceutical development.

Chiltern has a team of immunologists, rheumatologists and other medical professionals who specialize in the full spectrum of immunology and rheumatology clinical research — adding support and value to your project with their expertise and leadership. Working as a cross-functional group, the team collaborates with you to provide advice from medical, operational, regulatory and cost-efficiency perspectives. The relationships they foster with industry leaders and key professionals allow them to provide deeper insights and strategic guidance, leading to better patient experiences, improved clinical outcomes and expedited regulatory approvals.

In the last five years, Chiltern has conducted 129 immunology and rheumatology studies.

Immunology & Rheumatology

Investigators
Patients
Countries
Total Studies

Top Immunology & Rheumatology Indications From the Past Five Years

  • Asthma
  • Crohn’s disease
  • Cystic fibrosis
  • Multiple sclerosis
  • Psoriasis
  • Rheumatoid arthritis
  • Ulcerative colitis

Let us help you reach your program’s goals with a comprehensive range of collaborative services: